These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21645946)

  • 1. Synthesis and anticancer activity of (RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9H-purines.
    Conejo-García A; García-Rubiño ME; Marchal JA; Núñez MC; Ramírez A; Cimino S; García MÁ; Aránega A; Gallo MA; Campos JM
    Eur J Med Chem; 2011 Sep; 46(9):3795-801. PubMed ID: 21645946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin-3-ylmethyl)-9H-purines.
    Díaz-Gavilán M; Conejo-García A; Cruz-López O; Núñez MC; Choquesillo-Lazarte D; González-Pérez JM; Rodríguez-Serrano F; Marchal JA; Aránega A; Gallo MA; Espinosa A; Campos JM
    ChemMedChem; 2008 Jan; 3(1):127-35. PubMed ID: 18022976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine.
    López-Cara LC; Conejo-García A; Marchal JA; Macchione G; Cruz-López O; Boulaiz H; García MA; Rodríguez-Serrano F; Ramírez A; Cativiela C; Jiménez AI; García-Ruiz JM; Choquesillo-Lazarte D; Aránega A; Campos JM
    Eur J Med Chem; 2011 Jan; 46(1):249-58. PubMed ID: 21126804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine.
    Caba O; Díaz-Gavilán M; Rodríguez-Serrano F; Boulaiz H; Aránega A; Gallo MA; Marchal JA; Campos JM
    Eur J Med Chem; 2011 Sep; 46(9):3802-9. PubMed ID: 21684047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regiospecific microwave-assisted synthesis and cytotoxic activity against human breast cancer cells of (RS)-6-substituted-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or -9H-purines.
    Conejo-García A; Núñez MC; Marchal JA; Rodríguez-Serrano F; Aránega A; Gallo MA; Espinosa A; Campos JM
    Eur J Med Chem; 2008 Aug; 43(8):1742-8. PubMed ID: 18069093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anticancer activity of the (R,S)-benzofused 1,5-oxathiepine moiety tethered to purines through alkylidenoxy linkers.
    Kimatrai M; Conejo-García A; Ramírez A; Andreolli E; Da Silveira-Gomes A; García MA; Aránega A; Marchal JA; Campos JM
    ChemMedChem; 2011 Oct; 6(10):1854-9. PubMed ID: 21796794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and anticancer activity against the MCF-7 cell line of benzo-fused 1,4-dihetero seven- and six-membered tethered pyrimidines and purines.
    Núñez MC; Díaz-Gavilán M; Conejo-García A; Cruz-López O; Gallo MA; Espinosa A; Campos JM
    Curr Med Chem; 2008; 15(25):2614-31. PubMed ID: 18855682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies.
    Díaz-Gavilán M; Gómez-Vidal JA; Rodríguez-Serrano F; Marchal JA; Caba O; Aránega A; Gallo MA; Espinosa A; Campos JM
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1457-60. PubMed ID: 18194866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-proliferative activity of 2,6-dichloro-9- or 7-(ethoxycarbonylmethyl)-9H- or 7H-purines against several human solid tumour cell lines.
    Morales F; Ramírez A; Conejo-García A; Morata C; Marchal JA; Campos JM
    Eur J Med Chem; 2014 Apr; 76():118-24. PubMed ID: 24583351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiospecific synthesis of heterocycles linked to purines: different apoptosis modulation of enantiomers in breast cancer cells.
    García-Rubiño ME; Conejo-García A; Núñez MC; Carrasco E; García MA; Choquesillo-Lazarte D; García-Ruiz JM; Gallo MA; Marchal JA; Campos JM
    Curr Med Chem; 2013; 20(38):4924-34. PubMed ID: 24059234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel benzylidene-9(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
    Prinz H; Ishii Y; Hirano T; Stoiber T; Camacho Gomez JA; Schmidt P; Düssmann H; Burger AM; Prehn JH; Günther EG; Unger E; Umezawa K
    J Med Chem; 2003 Jul; 46(15):3382-94. PubMed ID: 12852768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
    Trávnícek Z; Szucová L; Popa I
    J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lignopurines: a new family of hybrids between cyclolignans and purines. Synthesis and biological evaluation.
    Castro MÁ; Miguel del Corral JM; García PA; Rojo MV; Bento AC; Mollinedo F; Francesch AM; San Feliciano A
    Eur J Med Chem; 2012 Dec; 58():377-89. PubMed ID: 23153810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation and docking studies of 4-amino-tetrahydroquinazolino[3,2-e]purine derivatives.
    Verones V; Flouquet N; Farce A; Carato P; Leonce S; Pfeiffer B; Berthelot P; Lebegue N
    Eur J Med Chem; 2010 Dec; 45(12):5678-84. PubMed ID: 20884092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel pyrimidine and purine derivatives of l-ascorbic acid: synthesis, one- and two-dimensional 1H and 13C NMR study, cytostatic and antiviral evaluation.
    Gazivoda T; Plevnik M; Plavec J; Kraljević S; Kralj M; Pavelić K; Balzarini J; De Clercq E; Mintas M; Raić-Malić S
    Bioorg Med Chem; 2005 Jan; 13(1):131-9. PubMed ID: 15582458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pyrimidine and purine derivatives of L-ascorbic acid: synthesis and biological evaluation.
    Raić-Malić S; Hergold-Brundić A; Nagl A; Grdisa M; Pavelić K; De Clercq E; Mintas M
    J Med Chem; 1999 Jul; 42(14):2673-8. PubMed ID: 10411487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents.
    Romero-Castro A; León-Rivera I; Avila-Rojas LC; Navarrete-Vázquez G; Nieto-Rodríguez A
    Arch Pharm Res; 2011 Feb; 34(2):181-9. PubMed ID: 21380799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiproliferative activity of 6-phenylaminopurines.
    Canela MD; Liekens S; Camarasa MJ; Priego EM; Pérez-Pérez MJ
    Eur J Med Chem; 2014 Nov; 87():421-8. PubMed ID: 25282265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine derivatives with heterocyclic moieties and related analogs as new antitumor agents.
    Fernández-Sáez N; Rubio-Ruiz B; Campos JM; Unciti-Broceta A; Carrión MD; Camacho ME
    Future Med Chem; 2019 Jan; 11(2):83-95. PubMed ID: 30644318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Aryl-N'-(chroman-4-yl)ureas and thioureas display in vitro anticancer activity and selectivity on apoptosis-resistant glioblastoma cells: screening, synthesis of simplified derivatives, and structure-activity relationship analysis.
    Goffin E; Lamoral-Theys D; Tajeddine N; de Tullio P; Mondin L; Lefranc F; Gailly P; Rogister B; Kiss R; Pirotte B
    Eur J Med Chem; 2012 Aug; 54():834-44. PubMed ID: 22809560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.